A Smarter Path for Dizziness: When and Why to Refer for Vestibular Therapy - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Smarter Path for Dizziness: When and Why to Refer for Vestibular Therapy

Dizziness is one of the most common yet complex complaints encountered across primary care, neurology, otolaryngology, and cardiology. It can present as vertigo, imbalance, or nonspecific lightheadedness. It can leave both patients and physicians searching for clear answers.

  • By

  • May 18, 2026

  • 6 min

Share

Clinical Report: A Smarter Path for Dizziness: When and Why to Refer for Vestibular Therapy

Overview

Dizziness is a complex symptom affecting various patient populations. Vestibular therapy at Atlantic Health CentraState Medical Center provides structured evaluation and targeted treatment for a range of dizziness-related conditions.

Background

Dizziness is a prevalent complaint across multiple medical specialties. Accurate diagnosis is crucial for effective management. Vestibular therapy offers a systematic approach to assess and manage these disorders.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Vestibular therapy addresses a variety of conditions including central vestibular dysfunction and post-stroke dizziness.
  • The therapy employs a structured evaluation process, including vestibulo-ocular reflex testing and gait assessments.
  • Individualized rehabilitation plans are developed.
  • Therapists utilize advanced tools for evaluation of eye movements.
  • One-on-one treatment is provided throughout the rehabilitation process.

Clinical Implications

Referral to vestibular therapy can assist in the assessment and management of dizziness.

Conclusion

Vestibular therapy provides structured evaluation and tailored treatment plans for managing dizziness.

Related Resources & Content

  1. Frontiers in Neurology, Editorial: Vestibular migraine: pathophysiology, diagnosis, and management, 2026
  2. Frontiers in Neurology, Editorial: Mechanisms of functional dizziness: a window for understanding space-motion cognition, 2026
  3. conexiant, Can Balance Predict Motion Sickness?
  4. GRACE-3 Dizziness - Emergency Medicine Clinical Practice Guideline | SAEM
  5. Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Evidence-Based Clinical Practice Guideline (CPG+), APTA
  6. Optometric Management — Contact Lens Management
  7. GRACE-3 Dizziness - Emergency Medicine Clinical Practice Guideline | SAEM
  8. Integrated diagnostic algorithm for acute vertigo combining TiTrATE, STANDING, and HINTS: a validation study in the emergency department. | Scientific Reports
  9. Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Evidence-Based Clinical Practice Guideline (CPG+) | APTA
  10. Frontiers | Virtual reality-based vestibular rehabilitation therapy in patients with acute unilateral vestibulopathy: a randomized controlled trial
  11. Efficacy of vestibular rehabilitation using unidirectional rotation paradigm in VOR asymmetry: systematic review and meta-analysis | European Archives of Oto-Rhino-Laryngology | Springer Nature Link
  12. https://emergencymed.org.il/wp-content/uploads/2025/02/Emergency-Department-Vestibular-Rehabilitation-Therapy-for-Dizziness-and-Vertigo.pdf
  13. Effect of vestibular rehabilitation therapy in patients with persistent postural perceptual dizziness: a systematic review and meta-analysis
  14. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
  15. Vestibular migraine | MedLink Neurology
  16. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society - PMC
  17. NEW CNS Guidelines—Vestibular Schwannoma - Congress of Neurological Surgeons (CNS)

Original Source(s)

A Smarter Path for Dizziness: When and Why to Refer for Vestibular Therapy

  • by

  • May 18, 2026

Related Content

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

Analysis of the quality and reliability of benign paroxysmal positional vertigo-related short videos on TikTok and Bilibili: A cross-sectional study

Case Report Describes Possible Betahistine–Suicidality Link

A single case report described suicidal ideation that resolved after betahistine discontinuation and recurred after rechallenge, but the findings cannot establish causality or quantify risk.